-
Posted by
Two Blokes Jul 29 -
Filed in
Stock
-
3 views
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Teva Pharmaceutical Industries (TEVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
